摘要
目的探讨低分子肝素钠在肺源性心脏病心力衰竭患者中的治疗效果。方法 86例肺源性心脏病心力衰竭患者,随机分为观察组和对照组,各43例。两组均给予常规治疗,观察组同时给予低分子肝素钠治疗。观察血液流变学指标,评定治疗效果。结果观察组治疗后的血液流变学指标优于对照组,差异有统计学意义(P<0.05)。观察组总有效率93.0%高于对照组的76.7%,差异有统计学意义(P<0.05)。结论低分子肝素钠在肺源性心脏病心力衰竭中的治疗效果显著,值得借鉴。
ObjectiveTo investigate curative effect of low molecular heparin sodium for pulmonary heart disease cardiac failure patients.MethodsA total of 86 pulmonary heart disease cardiac failure patients were randomly divided into observation group and control group, with 43 cases in each group. Both groups received conventional treatment, and the observation group received additional low molecular heparin sodium. Their hemodynamic indexes were observed for curative effect evaluation.ResultsThe observation group had better hemodynamic indexes after treatment than the control group, and their difference had statistical significance （P〈0.05）. Total effective rate of the observation group was higher as 93.0% than 76.7% of the control group, and their difference had statistical significance （P〈0.05）.ConclusionLow molecular heparin sodium provides remarkable curative effect for pulmonary heart disease cardiac failure, and it is worthy of referring.
出处
《中国实用医药》
2015年第21期25-26,共2页
China Practical Medicine
关键词
肺源性心脏病
心力衰竭
低分子肝素钠
Pulmonary heart disease
Cardiac failure
Low molecular heparin sodium
